阳普医疗
(300030)
| 流通市值：18.32亿 | | | 总市值：20.81亿 |
| 流通股本：2.72亿 | | | 总股本：3.09亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 421,468,424.66 | 293,161,345.69 | 141,154,613.58 | 644,621,152.95 |
| 营业收入 | 421,468,424.66 | 293,161,345.69 | 141,154,613.58 | 644,621,152.95 |
| 二、营业总成本 | 413,928,591.21 | 287,443,099.82 | 136,268,704.97 | 675,451,738.93 |
| 营业成本 | 252,701,132.63 | 175,775,125.32 | 85,046,020.66 | 384,303,722.59 |
| 税金及附加 | 6,466,081.16 | 4,838,625.31 | 3,156,073.9 | 8,520,357.18 |
| 销售费用 | 57,981,219.67 | 41,155,927.38 | 18,401,710.91 | 122,016,574.64 |
| 管理费用 | 65,667,453.05 | 46,306,139.37 | 21,470,202.56 | 106,736,480.81 |
| 研发费用 | 23,376,301.59 | 14,112,890.95 | 6,602,970.33 | 37,521,052.55 |
| 财务费用 | 7,736,403.11 | 5,254,391.49 | 1,591,726.61 | 16,353,551.16 |
| 其中:利息费用 | 9,290,301.4 | 6,919,098.94 | 2,076,271.13 | 16,564,431.3 |
| 其中:利息收入 | 1,432,358.02 | 974,971.15 | 453,012.7 | 2,315,181.04 |
| 加:公允价值变动收益 | -35,184,400 | 0 | - | 1,207,300 |
| 加:投资收益 | -12,979,218.06 | -12,301,561.61 | -8,949,461.99 | 6,236,063.69 |
| 资产处置收益 | 384,110.58 | 412,356.03 | 612,904.25 | 6,454,928.32 |
| 资产减值损失(新) | -166,748.49 | 6,008.07 | - | -35,048,173.31 |
| 信用减值损失(新) | -6,493,488.56 | -675,548.7 | - | 369,101.34 |
| 其他收益 | 6,022,099.69 | 4,027,521.13 | 2,056,531.07 | 10,797,973.97 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | -40,877,811.39 | -2,812,979.21 | -1,394,118.06 | -40,813,391.97 |
| 加:营业外收入 | 67,908.39 | 41,274.54 | 18,570.35 | 1,089,722.32 |
| 减:营业外支出 | 529,155.29 | 366,801.92 | 240,469.61 | 3,338,523.98 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | -41,339,058.29 | -3,138,506.59 | -1,616,017.32 | -43,062,193.63 |
| 减:所得税费用 | 3,293,277.28 | 1,367,951.21 | 1,271,650.33 | 17,158,101.42 |
| 六、净利润 | -44,632,335.57 | -4,506,457.8 | -2,887,667.65 | -60,220,295.05 |
| 持续经营净利润 | -44,632,335.57 | -4,506,457.8 | -2,887,667.65 | -60,220,295.05 |
| 归属于母公司股东的净利润 | -42,517,592.38 | -5,275,309.54 | -3,190,876 | -63,203,837.62 |
| 少数股东损益 | -2,114,743.19 | 768,851.74 | 303,208.35 | 2,983,542.57 |
| (一)基本每股收益 | -0.14 | -0.02 | -0.01 | -0.2 |
| (二)稀释每股收益 | -0.14 | -0.02 | -0.01 | -0.2 |
| 八、其他综合收益 | 17,683.97 | 11,419.19 | 13,784.53 | 1,939,282.8 |
| 归属于母公司股东的其他综合收益 | 17,683.97 | 11,419.19 | 13,784.53 | 1,939,282.8 |
| 九、综合收益总额 | -44,614,651.6 | -4,495,038.61 | -2,873,883.12 | -58,281,012.25 |
| 归属于母公司股东的综合收益总额 | -42,499,908.41 | -5,263,890.35 | -3,177,091.47 | -61,264,554.82 |
| 归属于少数股东的综合收益总额 | -2,114,743.19 | 768,851.74 | 303,208.35 | 2,983,542.57 |
| 公告日期 | 2024-10-26 | 2024-08-15 | 2024-04-27 | 2024-04-27 |
| 审计意见(境内) | | | | 标准无保留意见 |